SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals spurts on reporting 49% rise in Q1 consolidated net profit

04 Aug 2020 Evaluate

IOL Chemicals & Pharmaceuticals is currently trading at Rs. 756.50, up by 3.40 points or 0.45% from its previous closing of Rs. 753.10 on the BSE.

The scrip opened at Rs. 752.95 and has touched a high and low of Rs. 769.65 and Rs. 726.10 respectively. So far 127806 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 833.40 on 14-Jul-2020 and a 52 week low of Rs. 147.35 on 25-Mar-2020.

Last one week high and low of the scrip stood at Rs. 807.65 and Rs. 726.10 respectively. The current market cap of the company is Rs. 4477.18 crore.

The promoters holding in the company stood at 43.69%, while Institutions and Non-Institutions held 6.72% and 49.59% respectively.

IOL Chemicals and Pharmaceuticals has reported 49.48% rise in its net profit of Rs 127.54 crore for the quarter ended June 30, 2020 as against Rs 85.32 crore for the same quarter in the previous year. However, total income of the company decreased 6.09% at Rs 465.91 crore for Q1FY21 as compared Rs 496.12 crore for the corresponding quarter previous year.

IOL Chemicals & Pharmaceuticals is a leading organic chemicals manufacturer and supplier in India.

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×